Quanterix completes Akoya Biosciences acquisition for $20M cash plus stock Jul 8, 2025 09:08AM
Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum Jul 8, 2025 09:07AM
Quanterix (QTRX) Expands Reach with IVD and Large Reference Labs Jun 23, 2025 07:31AM
Quanterix Expands Reach with IVD and Large Reference Labs Jun 23, 2025 07:30AM
Quanterix to Present at Goldman Sachs Global Healthcare Conference Jun 6, 2025 09:41AM
View Older Stories

May 12, 2025 04:01PM Quanterix Releases Financial Results for the First Quarter of 2025
May 5, 2025 07:00AM Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025
Mar 17, 2025 04:01PM Quanterix Releases Financial Results for the Fourth Quarter of 2024
Mar 13, 2025 01:00PM Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025
Feb 13, 2025 05:55PM ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Feb 12, 2025 01:27PM ROSEN, A LEADING LAW FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Feb 9, 2025 11:16AM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Feb 3, 2025 06:54PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Jan 27, 2025 04:00PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Jan 24, 2025 03:19PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Jan 20, 2025 09:16AM ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Jan 17, 2025 06:18PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Jan 16, 2025 03:48PM ROSEN, A LONGSTANDING LAW FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Jan 14, 2025 05:55PM ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Jan 14, 2025 07:03AM Quanterix (QTRX) Provides Update on Financial Performance
Jan 14, 2025 07:00AM Quanterix Provides Update on Financial Performance
Jan 10, 2025 03:52PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Jan 7, 2025 05:11PM ROSEN, NATIONAL TRIAL COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Jan 6, 2025 09:30AM David R. Walt Receives National Medal of Technology and Innovation
Jan 4, 2025 08:54PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Jan 2, 2025 04:26PM Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Dec 31, 2024 03:03PM ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Dec 30, 2024 03:05PM ROSEN, A TRUSTED AND LEADING FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Dec 27, 2024 06:02PM ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Dec 26, 2024 06:42PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Dec 23, 2024 11:34PM ROSEN, RESPECTED INVESTOR RIGHTS COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Dec 22, 2024 11:04PM ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Dec 20, 2024 05:08PM ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Dec 19, 2024 05:08PM ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Dec 18, 2024 02:32PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Dec 17, 2024 07:00AM Quanterix (QTRX) Expands Capabilities with Strategic Acquisition of EMISSION
Dec 17, 2024 06:59AM Quanterix Expands Capabilities with Strategic Acquisition of EMISSION
Dec 16, 2024 04:14PM ROSEN, A GLOBALLY RESPECTED FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Dec 15, 2024 09:16AM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Dec 13, 2024 11:44AM ROSEN, A LEADING LAW FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX
Nov 22, 2024 05:00PM Quanterix Announces Receipt of Expected Notice from Nasdaq
Nov 12, 2024 04:01PM Quanterix Releases Preliminary Financial Results for the Third Quarter of 2024
Nov 5, 2024 04:00PM Quanterix To Report Third Quarter 2024 Financial Results on November 12, 2024
Oct 28, 2024 04:30PM New Multi-Marker Blood Test from Lucent Diagnostics Increases the Number of Patients Receiving Early Alzheimer’s Disease Diagnostic Information
Oct 2, 2024 04:00PM Quanterix Welcomes Ivana Magovčević-Liebisch, Ph.D., J.D. to Board of Directors
Sep 30, 2024 04:01PM Quanterix (QTRX) Announces Commercialization of p-Tau 217 Test Kit
Sep 30, 2024 04:00PM Quanterix Announces Commercialization of p-Tau 217 Test Kit
Aug 29, 2024 04:00PM Quanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare Conference
Aug 19, 2024 04:32PM Quanterix (QTRX) Appoints Jeffrey Elliott to its Board
Aug 19, 2024 04:32PM Jeffrey Elliott Appointed to Quanterix’s Board of Directors
Aug 8, 2024 04:00PM Quanterix Releases Financial Results for the Second Quarter of 2024
Aug 6, 2024 04:00PM Quanterix Presenting at Canaccord Genuity 44th Annual Growth Conference
Jul 31, 2024 04:00PM Quanterix To Report Second Quarter 2024 Financial Results
Jul 29, 2024 08:02AM Quanterix (QTRX) Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimer’s Disease Detection that is More Effective than Standalone Plasma p-Tau 217
Jul 29, 2024 08:00AM Quanterix Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimer’s Disease Detection that is More Effective than Standalone Plasma p-Tau 217
View Older Stories